Methoden vergelijken

	Beslissingsanalytische Modellering in Gezondheidseconomie	Markov-ketenmodel in de gezondheidseconomie
Vakgebied	Gezondheidseconomie	Gezondheidseconomie
Familie	Process / pipeline	Process / pipeline
Jaar van ontstaan	1975	1983
Grondlegger	Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital)	Beck & Pauker (medical decision analysis, Massachusetts General Hospital)
Type	Method	Method
Oorspronkelijke bron	Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234.	Beck, J. R., & Pauker, S. G. (1983). The Markov Process in Medical Prognosis. Medical Decision Making, 3(4), 419-458.
Aliassen	decision analysis, decision tree, decision model, health economic model	Markov model, state transition model, cohort simulation
Verwant	5	5
Samenvatting	Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions.	A Markov model is a decision-analytic tool that simulates disease progression through defined health states over time, calculating cumulative costs and quality-adjusted life years (QALYs) to enable cost-effectiveness analysis. Developed by Beck and Pauker in 1983, Markov models are now the standard framework for projecting long-term outcomes of health interventions, especially chronic diseases where patients transition between clinical states (treatment response, disease progression, remission, death). Used by health technology assessment bodies and pharmaceutical companies to predict intervention value beyond trial duration.